Home > Insider Trading > Filing (0001209191-18-055374)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1737287	Allogene Therapeutics Inc.	ALLO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611024	D David Chang	210 East Grand Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-15	40,000	$18.00	1,995,625	No	4	P	Direct
Common Stock	Acquisiton	2018-10-15	29,946	$0.00	1,101,838	No	4	C	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2018-10-15	5,704	$0.00	29,946	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	848,022	Indirect	See footnote
Common Stock	848,022	Indirect	See footnote

Footnotes

Each share of Series A Convertible Preferred Stock automatically converted into 5.25 shares of Common Stock upon the closing of the Issuer's initial public offering and had no expiration date.
Securities held in the name of the Chang 2006 Family Trust.
Securities held in the name of the Julia Chang 2018 Irrevocable Trust, of which the reporting person is Trustee and his daughter is the beneficiary.
Securities held in the name of the Robert Chang 2018 Irrevocable Trust, of which the reporting person is Trustee and his son is the beneficiary.